Valerio Therapeutics Société anonyme (EPA:ALVIO)

EPA:ALVIO Revenue

In the year 2025, Valerio Therapeutics Société anonyme had annual revenue of 2.57M EUR with 43.50% growth. Valerio Therapeutics Société anonyme had revenue of 2.45M in the half year ending December 31, 2025, with 35.94% growth.

• Revenue: 2.57M
• Revenue Growth: +43.50%
• P/S Ratio: 32.22
• Revenue / Employee: 102.92K
• Employees: 25
• Market Cap: 82.91M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	2.57M	780.00K	43.50%
Dec 31, 2024	1.79M	-7.00K	-0.39%
Dec 31, 2023	1.80M	357.00K	24.74%
Dec 31, 2022	1.44M	-2.62M	-64.48%
Dec 31, 2021	4.06M	2.29M	128.72%

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

May 9, 2026

Data Sources Report a data error